As Sandoz and Just-Evotec Biologics announce a new partnership, Celltrion secures tender wins in Italy and Belgium, and Alvotech begins testing its golimumab biosimilar in patients with rheumatoid arthritis. Sandoz and Just-Evotec Biologics Partnership...

SEOUL, May 22 (Yonhap) — South Korea will send an economic delegation to Estonia, Lithuania and Finland this week to explore ways to boost cooperation on trade and various new industry fields, such as...

PRESS RELEASE Published May 23, 2023...

PRESS RELEASE Published May 24, 2023 Newark, New Castle, USA new report, titled Stomach Cancer Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and...

Panelists at Asembia 2023 championed greater involvement of specialty pharmacists, payers, and providers in efforts to improve biosimilar acceptance and advocate for biosimilar policy changes. The panel discussion took place during a session entitled...

KOSPI 200 Closing Price List-4  Yonhap News Agency Source link...

The Microscopic Polyangiitis (MPA) Treatment report is an in-depth examination of the global Microscopic Polyangiitis (MPA) Treatment’s general consumption structure, development trends, sales techniques, and top nations’ sales. The research looks at well-known providers in the...

The US Food and Drug Administration (FDA) has approved Yuflyma (adalimumab-aaty), a high-concentration (100mg/mL) and citrate-free formulation of AbbVie’s (NYSE: ABBV) mega-blockbuster drug Humira (adalimumab) biosimilar, the US subsidiary of South Korean biosimilars developer...

FDA Grants Full Approval to Pfizer’s Oral COVID-19 Drug The FDA Thursday granted full approval to Pfizer’s COVID-19 oral antiviral pill, nirmatrelvir/ritonavir (Paxlovid), for use by adults at high risk for progression to acute...

The Antiviral Combination Therapies research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential...